Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Rani Therapeutics Holdings, Inc. (RANI) had Weighted-Average Shares Outstanding (Diluted) of 187.17M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.71M |
|
$-7.39M |
|
-- |
|
$1.71M |
|
$10.54M |
|
$-8.83M |
|
$0.41M |
|
$-8.42M |
|
$-8.42M |
|
$-8.42M |
|
$-8.42M |
|
$-8.42M |
|
$-8.42M |
|
$-8.83M |
|
$-8.94M |
|
187.17M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
187.17M |
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$56.52M |
|
$0.53M |
|
$4.32M |
|
$60.84M |
|
$10.64M |
|
-- |
|
$2.22M |
|
$12.86M |
|
$47.98M |
|
$47.98M |
|
$47.98M |
|
136.47M |
|
| Cash Flow Statement Financials | |
$-15.52M |
|
$-17.01M |
|
$18.78M |
|
$18.82M |
|
$5.07M |
|
$-13.75M |
|
$4.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-516.86% |
|
-516.86% |
|
-- |
|
-493.03% |
|
-432.73% |
|
$-15.57M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.84 |
|
107.60 |
|
-17.55% |
|
-17.55% |
|
-13.84% |
|
-17.55% |
|
$0.35 |
|
$-0.08 |
|
$-0.08 |
|